Page 8 - Vered Caplan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NA Proactive news snapshot: KWESST Micro Systems, Sassy Resources, Power REIT, Delta 9 Cannabis UPDATE … A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive KWESST Micro Systems Inc (CVE:KWE) (OTCQB:KWEMF) announced plans to hold an investor update call at 2 pm ET on Tuesday, May 11. Executive Chairman David Luxton will describe the significance of the company's acquisition of Low Energy Cartridge (LEC) systems and the go-to-market strategy for the LEC, the world's first cartridge based no...

Orgenesis enters second phase of collaboration with Hospital Infantil Universitario Niño Jesús in Madrid with exclusive license to commercialize Celyvir solid tumor therapy The collaboration is focused on advancing clinical development and commercialization of the oncolytic virus-based cell therap...

Orgenesis Enters Second Phase of Collaboration with Hospital Infantil Universitario Niño Jesús in Madrid with Exclusive License to Commercialize Celyvir Solid Tumor Therapy The collaboration is focused on advancing clinical development and commercialization of the oncolytic virus-based cell therapy March 11, 2021 07:00 ET | Source: Orgenesis Inc. Orgenesis Inc. GERMANTOWN, Md., March 11, 2021 (GLOBE NEWSWIRE) -- . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene ther...

Search jobs 10-Mar-2021 Orgenesis Mobile Processing Units and Labs (OMPULs) to be Used for Point-of-Care Production and Commercialization of Cell and Gene Therapies in Collaboration with Dong-a University Hospital and Cure Therapeutics in South Korea Orgenesis Mobile Processing Units and Labs (OMPULs) to be Used for Point-of-Care Production and Commercialization of Cell and Gene Therapies in Collaboration with Dong-a University Hospital and Cure Therapeutics in South Korea   . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotec...

Share: Revenue increases 96% to $7.7 million for 2020 Projects to more than double in revenue for 2021 based on current contracts already in hand Orgenesis to host conference call today at 8:30AM ET GERMANTOWN, Md., March 09, 2021 (GLOBE NEWSWIRE) -- . (NASDAQ:ORGS) ("Orgenesis" or the "Company"), a global biotech company working to unlock the full potential of cell and gene therapies (CGTs), today reported financial results for the year ended December 31, 2020 and provided a business update. Vered Caplan, CEO of Orgenesis, commented, "Just over a year ago, we completed the sale of one of ...